Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hypertension Diagnostics PulseWave 510(k) Submission Anticipated This Year

This article was originally published in The Gray Sheet

Executive Summary

Hypertension Diagnostics plans to submit a 510(k) by the end of 1998 for its HDI/PulseWave DO-2020 cardiovascular profiling instrument, the company states in a May 19 filing with the Securities and Exchange Commission for an initial public offering.

You may also be interested in...



Hypertension Diagnostics Plans Second CVProfilor 510(k) Submission By July

Hypertension Diagnostics, Inc. is conducting additional prospective clinical trials of its CVProfilor DO-2020 cardiovascular profiling instrument to support a second 510(k) submission after an initial submission was deemed inadequate by FDA, the firm says. The filing is expected in the first half of this year.

Volume-Based Purchasing Looms Larger In Post-Coronavirus China

China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.

UsernamePublicRestriction

Register

MT010087

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel